Figures computed from official regulatory filings — .
Analysttarget 3.83 USD (+212%) · consensus 4.67/5 · 3 buy · 0 hold · 0 sell
Ownershipinsiders 55.39% · institutions 5.89% · short 1.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Vivani Medical, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
239 buys41 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Baldor Anthony | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Le Truc | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dwyer Donaldtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Le Truc | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Baldor Anthony | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dwyer Donaldtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mendelsohn Adam | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mendelsohn Adam | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Porter Lisa Ellen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Porter Lisa Ellen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BRADBURY DANIELtrack record | AwardD (derivative) | $10.4K | SEC |
| Williams Greggtrack record | Buy | $1M | conv 18 | SEC |
| Moretti August J | AwardD (derivative) | $43.9K | SEC |
| BRADBURY DANIELtrack record | AwardD (derivative) | $44.5K | SEC |
| Mendelsohn Aaron | AwardD (derivative) | $44.5K | SEC |
| Williams Greggtrack record | AwardD (derivative) | $44.5K | SEC |
| Larson Alexandra L.P. | AwardD (derivative) | $44.5K | Unusual size | SEC |
| Williams Greggtrack record | Buy | $2M | conv 33 | SEC |
| Williams Greggtrack record | Buy | $2M | conv 33 | SEC |
| Williams Greggtrack record | Buy | $2M | conv 34 | SEC |
| Williams Greggtrack record | Buy | $1.4M | conv 29 | SEC |
| Williams Greggtrack record | Buy | $333.3K | conv 26 | SEC |
| Williams Greggtrack record | Buy | $333.3K | conv 26 | SEC |
| Williams Greggtrack record | Buy | $1.6M | conv 31 | SEC |
| Williams Greggtrack record | Buy | $2M | conv 32 | SEC |